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Objective: The objective of this study was to evaluate the effective new phytocomponents from Calophyllum inophyllum ethanol leaf extract against 
breast cancer target protein of epidermal growth factor receptor (EGFR) using in silico docking studies.
Methods: The identification of compounds was done by gas chromatography-mass spectrometry (GC-MS) analysis. The in silico docking studies were 
carried out using Discovery Studio 4.0 software.
Results: The GC-MS analysis of ethanol leaf extract revealed the presence of eleven compounds. The docking analysis has exhibited moderate to potent 
inhibition with a range of dock score 3-55. 2H-Benzo(cd)pyrene-2,6(1,H)-dione, 3,5,7,10-tetrahydroxy-compound showed the dock score of 55.427.
Conclusion: The results revealed out that the compounds present in C. inophyllum can inhibit the EGFR protein. The plant possesses anticancer 
potential because of the various bioactive compounds presence which is mainly responsible for anticancer activity.
Keywords: Calophyllum inophyllum, Gas chromatography-mass spectrometry analysis, In silico, Epidermal growth factor receptor protein, Discovery 
Studio.
INTRODUCTION
The epidermal growth factor (EGF) is the prototype of a large family 
of peptide ligands that bind to cell membrane receptors and activate a 
myriad of intracellular signaling pathways to control tumor cell growth, 
proliferation, survival, metastasis, and angiogenesis [1]. The EGF 
receptor (epidermal growth factor receptor [EGFR], ErbB1, or HER1) is 
one of a four member family of transmembrane receptors that, similar 
to HER2, are frequently overexpressed in cancer cells, correlating with 
poor prognosis [2]. EGFR therefore presents a rational target for the 
development of novel anticancer therapies. The best-known agents 
targeting EGFR is the most advanced clinical development include 
cetuximab, gefitinib, and erlotinib [3]. Unfortunately, currently, clinical 
results are disappointing due to several mutations on the EGFR kinase 
domain that is associated with a number of human cancer and brain 
tumors. Hence, there is a need for the development of novel EGFR 
inhibitors. It is reported that natural products derived from medicinal 
herbs, food sources, and marine organism are able to inhibit EGFR 
signaling [4].
Calophyllum inophyllum L. belongs to the family of Clusiaceae and is 
commonly known as “Punnai” in Tamil. It is a tree that can grow 8-20 m 
tall with a broad spreading crown of irregular branches, which exudes 
white latex when bruised. The leaves have opposite arrangements and 
are petiolate, thick, and shiny with numerous parallel secondary veins. Its 
flower arranged in axillary cymes and has a sweet, lime-like fragrance [5]. 
C. inophyllum L. ethanol leaf extract showed potent anticancer activity 
against MCF-7 breast cancer cell line [6]. C. inophyllum leaves extract 
showed more anti-inflammatory activity compared with C. inophyllum 
stem bark extract [7]. The (+) - calanolide A and inophyllum B isolated 
from Calophyllum lanigerum Miq. and C inophyllum L. showed strong 
activity against human immunodeficiency virus type 1 [8]. Comparative 
analgesic studies of leaf and stem bark of C. inophyllum in Swiss albino 
mice using acute oral toxicity assay and the results suggested that leaf 
extract showed more activity compared with stem bark extract [9].
In silico technique is an inexpensive technique that shortens the length 
of time spending in testing the efficacy drugs. Hence, the present 
study focused on the identification of bioactive compounds present in 
C. inophyllum ethanol leaf extract through gas chromatography-mass 
spectrometry (GC-MS) analysis and to screen the potential bioactive 
compounds as an anticancer agent by molecular docking analysis 
studies against EGFR protein.
MATERIALS AND METHODS
Collection of plant material
The leaves of C. inophyllum were collected from Ramakrishna Mission 
Vivekananda College Campus, Chennai, Tamil Nadu, India. The plant 
material was identified and authenticated by Botanical Survey of India 
(BSI) with ref no. BSI/SRC/5/23/2016/Tech/386.
Preparation of leaf extract
The fresh leaves were collected and washed with running tap water, 
chopped into small pieces and then kept in the shade dry for 30 days 
and then grounded using electric blender. About 50 g of powdered 
leaves were extracted with 300 ml of ethanol in soxhlet apparatus for 
6 hrs. The extract was then concentrated at reduced pressure using 
rotary evaporator and stored in vials at 4°C until further analysis [10].
GC-MS analysis
The composition of the chloroform extract was established by GC-
MS analysis. The analysis was performed on a JEOL GCMATE II GC-
MS system in EI/CI mode equipped with a split/splitless injector 
(220°C), at a split ratio of 1/10, using a VF-1MS fused silica capillary 
column (30 m×0.25 mm i.d.; film thickness: 0.25 mm). The oven 
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temperature was programed from 60°C (5 minutes) to 280°C at a rate 
of 4°C/minutes and held at the temperature for 10 minutes. Helium 
was used as a carrier gas at a flow rate of 0.8 ml/minute. Mass spectra 
were taken at 70 eV; a scan interval of 0.5 seconds and fragments 
from 40 to 550 Da. The spectrums of the components were compared 
with the database of known spectrum components stored in the NIST 
library [11].
In silico docking analysis
Generation of ligand
Structures of compounds present in C. inophyllum ethanol leaf extract 
and were attained from PUBCHEM compounds database. The same was 
used to predict properties of ligand such as hydrogen donors, acceptors, 
logP value, refractivity, pH, and molecular weight (MW). These 
compounds were screened for drug-likeliness according to Lipinski’s 
rule of five [12].
Absorption, distribution, metabolism, excretion, and toxicity 
(ADMET) and Lipinski’s rule of five
The 2D structures were subject to ADMET analysis for solubility, 
intestinal absorption, hepatotoxicity, plasma protein binding ability, 
blood-brain barrier penetration, cytochrome P450 inhibition, and 
AMES mutagenicity using Discovery Studio 4.0 [13,14].
Preparation of receptor
The crystal structure of EGFR protein was retrieved from Research 
Collaboratory for Structural Bioinformatics Protein Data Bank (PDB ID: 
1IVO) (http://www.rcsb.org/pdb/home/home.do) [15,16].
Docking analysis
Docking is virtual screening of a database of compounds (ligands) 
and predicting the strongest binders based on various scoring 
functions. Accelrys Discovery Studio 4.0 [17] was used for docking. 
Before docking, the ligands were prepared using the “prepare ligand” 
module. Receptor-ligand interactions were further optimized by 
molecular dynamics and clean geometry of Discovery Studio. Force 
field is applied in Discovery Studio and is energies and forces of each 
particle of the system and also defines the positional relationship 
between atoms that determine their energy. The docking scores, 
internal energy of ligands, and potential mean force (PMF) values are 
estimated. Root-mean-square distance (RMSD) between the docked 




The GC-MS results showed presence of eleven bioactive compounds 
in ethanol leaf extract of C. inophyllum. The identification of the 
compounds was confirmed based on the peak area, retention time (RT), 
and molecular formula. The active principle with their RT, molecular 
formula, MW, and peak area in percentage are presented in Fig. 1 and 
Table 1.
In silico docking analysis
Lipinski properties
The drug-likeness score of the compounds of C. inophyllum ethanol 
leaf extract was tested within the help of Lipinski’s rule of five. 
The physicochemical properties of the compounds obtained from 
C. inophyllum ethanol leaf extracts that accept the Lipinski’s rule of five, 
as tabulated in Table 2. Six compounds (ligands) showed drug-likeness 
properties and other five failed in Lipinski’s rule of five.
The ligands were subjected to predict ADMET properties using the 
Discovery Studio client, the toxicity prediction module of the software. 
The predicted ADMET properties are tabulated in Table 3 and Fig 2. 
All the compounds exhibited non-mutagenicity as predicted by TOPKAT 
AMES mutagenicity. The solubility levels showed in between 1 and 3 in 
all compounds.
The six compounds passed in Lipinski’s rule of five and ADMET property 
and their structures were retrieved from PUBCHEM and CHEMSPIDER 
database was shown in Fig. 3a-f.
The target EGFR protein structure was retrieved from PDB (PDB ID: 
1IVO) with 34 active sites predicted in Discovery Studio 4.0 (Fig. 4).
Docking analysis
Docking with Discovery Studio showed the top two drug candidates 
namely 2H-Benzo(cd)pyrene-2,6(1,H)-dione, 3,5,7,10-tetrahydroxy-1 
and Benzo(b,t)-1,2,4-triazolo(4,3,-d)=1,4-Oxazepine-6, 7-dicarbonitrile, 
3-phenyl. The ligand internal energies and dock score of the candidates 
are shown in Table 4. The docking results showed that all the ligands 
with high internal energies, namely, 2H-Benzo(cd)pyrene-2,6(1,H)-
dione, 3,5,7,10-tetrahydroxy-1, and Benzo(b,t)-1,2,4-triazolo(4,3,-
d)=1,4-Oxazepine-6, 7-dicarbonitrile, 3-phenyl occupied the active site 
of EGFR protein and ligand internal energy is 2.19 and −4.173 Kcal/mol 
with a dock score of 55.427 and 50.325, respectively (Fig. 5a-d). The 
standard anticancer drug 5-fluorouracil showed dock score of 50.565 
with −0.187 ligand internal energy.
Fig. 1: Gas chromatography-mass spectrometry of ethanol leaf extract of Calophyllum inophyllum
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The binding mode of the ligands within the active site of EGFR protein 
was analyzed using Discovery Studio 4.0. It gives 2D visualization of 
the drug and receptor. The binding interaction of 2H-Benzo(cd)pyrene-
2,6(1,H)-dione, 3,5,7,10-tetrahydroxy-1 (Fig. 5a) with the EGFR, with 
LYS A:455, LEU A:429, and ARG A:509 was noted and the binding 
interaction of Benzo(b,t)-1,2,4-triazolo(4,3,-d)=1,4-Oxazepine-6, 
7-dicarbonitrile, 3-phenyl with the EGFR, with THR A:249, ASN B:86, 
and LYS B:4 was noted. The binding interaction of 5-fluorouracil (Table 
and Fig. 6a-d) with the EGFR, with GLU A:133 and HIS A:159 was noted 
(Table 5).
DISCUSSION
Malarvizhi et al. 2011 reported of C. inophyllum L. leaf extract using 
alcoholic solvents by yielded seventeen compounds [18]. By comparing 
the earlier reports, two compounds are similar, namely, phytol and 
hexadecanoic acid, whereas other nine compounds were different. The 
difference in plant components from previous study might arise from 
different extraction procedure, whereas the present study of ethanol 
leaf extract exhibited important bioactive compounds which possess 
various biological activities.
Table 1: GC-MS profile of ethanol leaf extract of Calophyllum inophyllum







1 11.18 Caryophyllene 5322111 204.35 C15H24 5.52
2 11.68 Z, Z, Z-1,4,6,9-nonadecatetraene 5362676 260.45 C19H32 2.97
3 12.53 1,4-Methanoazalen-3-ol, decahydro-1, 
5,5,8a-tetramethyl 15-(1a, 3a, 3aa, 4a, 8aa)
6432447 222.36 C15H26O 4.02
4 15.95 Z, E-2-Methyl-3, 13, Octadecadein-1-ol 5364521 280.48 C19H36O 3.95
5 16.60 E, E, Z-1,3,12-Nonadecatriene-5,14-diol 5364768 294.47 C19H34O2 0.51
6 17.83 Hexadecanoic acid, ethyl ester 12366 284.47 C18H36O2 13.59
7 19.10 Phytol 5280435 296.53 C20H40O 35.45
8 19.52 Dasycarpidan-1-methanol, acetate (ester) 550072 326.43 C20H26N2O2 1.41
9 25.48 Benz(b, t)-1,2,4-triazolo(4,3,-d)=1,4-Oxazepine-6, 
7-dicarbonitrile, 3-phenyl
CHEM SPIDER ID 
549034
361.55 C22H11N5O 11.48
10 27.28 2H-Benzo(cd)pyrene-2,6(1, H)-dione, 
3,5,7,10-tetrahydroxy-1
5282060 376.35 C22H16O6 15.95
11 27.63 n-Heptane, 1,1-bi (4,4-dimethylhexan-2,6-dione-1-yl) CHEM SPIDER ID 
309203
376.53 C23H36O4 51.20
GC-MS: Gas chromatography-mass spectrometry, RT: Retention time
Table 2: Physicochemical properties of ligands accepting the Lipinski’s rule of five







1 Caryophyllene 204.35 0 0 4.75
2 Z, Z, Z-1,4,6,9-nonadecatetraene 260.48 0 0 7.31
3 1,4-Methanoazalen-3-ol, decahydro-1, 5,5,8a-tetramethyl 15-(1a, 3a, 3aa, 
4a, 8aa)
222.36 1 1 3.29
4 Z, E-2-Methyl-3, 13, Octadecadein-1-ol 280.48 1 1 6.78
5 E, E, Z-1,3,12-Nonadecatriene-5,14-diol 294.47 2 2 5.55
6 Hexadecanoic acid, ethyl ester 284.47 0 2 6.96
7 Phytol 296.53 1 1 7.33
8 Dasycarpidan-1-methanol, acetate (ester) 326.43 1 4 3.44
9 Benzo (b, t)-1,2,4-triazolo (4,3,-d)=1,4-Oxazepine-6, 7-dicarbonitrile, 
3-phenyl
361.55 0 6 4.31
10 2H-Benzo(cd)pyrene-2,6(1, H)-dione, 3,5,7,10-tetrahydroxy-1 376.35 4 6 3.83
11 n-Heptane, 1,1-bi(4,4-dimethylhexan-2,6-dione-1-yl) 376.53 0 4 4.17
Table 3: ADMET profile for the test ligands from Calophyllum inophyllum










1 Caryophyllene 2 0 False False True NM
2 Z, Z, Z-1,4,6,9-nonadecatetraene 1 4 False True True NM
3 1,4-Methanoazalen-3-ol, decahydro-1, 
5,5,8a-tetramethyl 15-(1a, 3a, 3aa, 4a, 8aa)
2 1 True False True NM
4 Z, E-2-Methyl-3, 13, Octadecadein-1-ol 2 0 False True True NM
5 E, E, Z-1,3,12-Nonadecatriene-5,14-diol 3 0 False False True NM
6 Hexadecanoic acid, ethyl ester 2 0 False False True NM
7 Phytol 2 4 False False True NM
8 Dasycarpidan-1-methanol, acetate (ester) 2 1 True True True NM
9 Benzo(b, t)-1,2,4-triazolo(4,3,-d)=1,4-Oxazepine-6, 
7-dicarbonitrile, 3-phenyl
1 2 True False True NM
10 2H-Benzo(cd)pyrene-2,6(1, H)-dione, 
3,5,7,10-tetrahydroxy-1
2 0 True False True NM
11 n-Heptane, 1,1-bi (4,4-dimethylhexan-2,6-dione-1-yl) 2 0 False False True NM
BBB: Blood-brain barrier, PPB: Plasma protein binding, NM: Non-mutagen, ADMET: Absorption, distribution, metabolism, excretion, and toxicity
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Molecular docking discovers the binding geometry of two interacting 
molecules with known structures. It predicts the preferred orientation 
of receptor and ligand to each other to form a stable complex [19,20]. 
Currently, the use of computers to determine the binding of datasets 
of small molecules to known receptors is a major component of drug 
discovery. Rule of five evaluates certain pharmacological, biological, 
and ADME properties of the ligand [12,13]. The compound that 
passed Lipinski’s rule of five to be further pursued as a potential 
drug because it would likely lack properties essential in its ADME. 
The only six compounds (e.g. 2H-Benzo(cd)pyrene-2,6(1,H)-dione, 
3,5,7,10-tetrahydroxy-1 and n-Heptane, 1,1-bi(4,4-dimethylhexan-
2,6-dione-1-yl)) had drug-like properties. The solubility levels of the 
compounds were in the range 1-3, indicating good solubility. Toxicity 
profile of the designed derivatives was predicted using TOPKAT-like 
AMES mutagenicity for ligands. The results showed all the ligands were 
non-mutagen in AMES test [21]. The PMF values developed based on 
statistical analysis of the 3D structures of protein-ligand complexes, 
scores are calculating by summing pairwise interaction terms overall 
interatomic pairs of the receptor-ligand complex, a higher score 
indicates a stronger receptor-ligand binding affinity [22]. If the RMSD 
of the docked pose is less than or equal to 1.0Å from the experimentally 
observed conformation, the prediction is regarded to be successful. All 
the binding ligands the RMSD values is zero, hence the receptor-ligand 
interaction to be strong binding.
This study showed that C. inophyllum plant contains a few compounds 
that are capable of binding to and inhibiting the EGFR protein and 
thereby preventing cell proliferation in an uncontrolled manner. 
From the ADMET studies, the 2H-Benzo(cd)pyrene-2,6(1,H)-dione, 
3,5,7,10-tetrahydroxy-1 compound is a better drug candidate and 
showed the least adverse effects. Hence, 2H-Benzo(cd)pyrene-2,6(1,H)-
dione, 3,5,7,10-tetrahydroxy-1 could prove to be a probable anticancer 
drug. Mukund et al., (2014) reported the GC-MS compounds, namely, 
Bis(2-ethyl hexylpthalate), Hexadecenoic acid methyl ester, and Phytol 
showed -7.9 Kcal/mol, -5.3 Kcal/mol, and -5.2 Kcal/mol binding 
energy against EGFR protein, respectively [23]. In the present study, 
the 2H-Benzo(cd)pyrene-2,6(1,H)-dione, 3,5,7,10-tetrahydroxy-1 
compound showed the highest dock value of 55.427, but the compounds 
such as n-Heptane, 1,1-bi(4,4-dimethylhexan-2,6-dione-1-yl) and 
Dasycarpidan-1-methanol,acetate(ester) showed lowest dock values of 
37.076 and 3.165, respectively.
CONCLUSION
However, this molecular docking study is only one way of predicting the 
activity of the molecules involved. Therefore, in vitro and in vivo studies 
need to be performed on animal models to confirm the anticancerous 
activity of these compounds. The role of some important amino acids 
involved in the appropriate binding of inhibitors with the active site 
Fig. 2: Prediction of absorption, distribution, metabolism, 
excretion, and toxicity properties of compounds (X axis indicates 
the solubility of the compounds; Y axis indicates the logP values)
Fig. 4: Epidermal growth factor receptor Protein Data Bank 
ID: 1IVO with receptor cavity (total active sites: 34)
Fig. 3: (a-f) Chemical structures of ligands. 
(a) Caryophyllene, (b) 1,4-Methanoazalen-3-ol, decahydro-1, 
5,5,8a-tetramethyl 15-(1a,3a,3aa,4a,8aa), (c) Dasycarpidan-
1-methanol,acetate(ester), (d) Benzo(b,t)-1,2,4-
triazolo(4,3, d)=1,4-oxazepine-6, 7-dicarbonitrile, 3-phenyl, 





Fig. 5: Interaction of epidermal growth factor receptor 
(EGFR) with ligands (3D View). (a) Interaction of EGFR with 
2H-Benzo(cd)pyrene-2,6(1,H)-dione, 3,5,7,10-tetrahydroxy-1, 
(b) Interaction of EGFR with Benzo(b,t)-1,2,4-triazolo(4,3, d)=1,4-
Oxazepine-6, 7-dicarbonitrile, 3-phenyl, (c) Interaction of EGFR 
with n-Heptane, 1,1-bi (4,4-dimethylhexan-2,6-dione-1-yl), 
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Table 4: Dock score and ligand internal energy of docked ligands using Discovery Studio
S. No. Compound name Binding 
site





1 Caryophyllene - - - - -
2 1,4-Methanoazalen-3-ol, decahydro-1, 5,5,8a-tetramethyl 15-(1a, 3a, 
3aa, 4a, 8aa)
- - - - -
3 Dasycarpidan-1-methanol,acetate (ester) 6 13.51 39.078 3.165 0.00
4 Benzo(b, t)-1,2,4-triazolo(4,3,-d)=1,4-Oxazepine-6, 7-dicarbonitrile, 
3-phenyl
5 107.06 −4.173 50.325 0.00
5 2H-Benzo(cd)pyrene-2,6(1, H)-dione, 3,5,7,10-tetrahydroxy-1 6 31.33 2.19 55.427 0.00
6 n-Heptane, 1,1-bi(4,4-dimethylhexan-2,6-dione-1-yl) 13 61.75 8.557 37.076 0.00
7 Standard drug (5-fluorouracil) 23 27.26 −0.187 50.565 0.00
PMF: Potential mean force, RMSD: Root-mean-square distance
of EGFR protein can be helpful for designing better drugs to combat 
cancer.
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Fig. 6: Interaction of ligands with amino acid residues (a). 2H-Benzo(cd)pyrene-2,6(1,H)-dione, 3,5,7,10-tetrahydroxy-1 (b). Benzo(b,t)-
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Table 5: Docking score with hydrogen bond interaction of detected binding site of EGFR protein crystal
S. No. Ligand name No. of hydrogen 
bonds





1 2H-Benzo(cd)pyrene-2,6(1, H)-dione, 
3,5,7,10-tetrahydroxy-1




















2 Benzo(b, t)-1,2,4-triazolo(4,3,-d)=1,4-Oxazepine-6, 
7-dicarbonitrile, 3-phenyl
3 A:THR249:HG1 - C22 H11 N5 O: N15
B:ASN86:HD22 - C22 H11 N5 O: N15




3 n-Heptane, 1,1-bi(4,4-dimethylhexan-2,6-dione-1-yl) 2 B:LYS188:HZ1 - C23 H36 O4:O4
B:LYS188:HE1 - C23 H36 O4:O4
2.29092
2.61881














EGFR: Epidermal growth factor receptor
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